Table 2 Demographic, clinical, biochemical and angiographic characteristics in low and intermediate-high SYNTAX score (SS) group

Age, years

65 (57–71)

63 (58–75)

Male gender, n (%)

114 (67.9%)

22 (66.7%)

Hypertension, n (%)

107 (63.7%)

20 (60.6%)

Diabetes, n (%)

40 (23.8%)

9 (27.3%)

Smoking, n (%)

25 (14.9%)

5 (15.2%)

BMI, kg/m²

24.9 ± 3.5

24.2 ± 2.7

WBC, 10⁹/L

6.6 (5.3–8.0)

7.0 (5.6–8.8)

NEUT, 10⁹/L

4.1 (3.3–5.4)

4.5 (3.6–5.9)

LYM, 10⁹/L

1.7 (1.3–2.1)

1.9 (1.3–2.2)

NLR

2.4 (1.8–3.4)

2.6 (2.0–3.6)

Platelet, 10⁹/L

174 (141–212)

185 (145–225)

RDW

12.9 (12.5–13.3)

12.8 (12.5–13.4)

Hemoglobin, g/L

129.8 ± 14.6

128.1 ± 23.7

IL-6, pg/ml

6.5 (4.3–9.2)

14.0 (11.1–24.8)

hs-CRP, mg/l

4.5 (1.3–9.0)

11.8 (8.7–20.0)

Glucose, mmol/L

5.7 ± 2.5

5.6 ± 1.4

TC, mmol/L

3.9 ± 1.0

4.0 ± 1.0

Triglyceride, mmol/L

1.4 (1.0–2.0)

1.6 (1.2–1.8)

HDL-c, mmol/L

1.2 (1.1–1.4)

1.1 (1.0–1.3)

LDL-c, mmol/L

2.2 ± 0.8

2.4 ± 0.9

apoB, g/L

0.8 (0.6–0.9)

0.9 (0.6–1.1)

apoA1, g/L

1.0 ± 0.2

1.1 ± 0.2

Creatinine, umol/L

69.4 (57.7–85.2)

68.5 (57.2–87.6)

eGFR, ml/min

86.3 (67.4–113.1)

86.1 (66.8–104.2)

Albumin, g/L

39.4 (37.5–41.5)

38.6 (35.9–40.6)

Fibrinogen, g/L

3.0 (2.6–3.8)

3.4 (2.8–4.0)

D-Dimer, ug/ml

0.3 (0.2–0.5)

0.4 (0.2–0.6)

LVEF, %

62.0 (58.0–65.0)

62.0 (53.0–65.0)

SS

12.0 (7.0–15.8)

26.0 (23.5–28.5)

SS II

24.5 (19.9–31.3)

30.5 (24.5–37.5)

rSS

2.0 (0–5.0)

10.0 (4.0–16.8)